ARCHIVES

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

This article is from The Cancer Letter archive.

Vol. 27 No. 31 | August 31, 2001

Download PDF Visit The Full Archive

Related Articles

ACS Says NCI Needs $1.1 Billion, Cites Progress In Prevention, Control

April 29, 1977

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

November 23, 1979

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

DePinho Seeks New Review of Incubator Proposal

June 1, 2012

Some Children With Hodgkin’s Disease Can Reduce Or Skip Radiation, Study Finds

October 29, 2004

Hammond Resigns As Director Of USC Comp Center

May 29, 1981